U.S. Life Sciences Stock News

NasdaqGS:ONB
NasdaqGS:ONBBanks

A Look At Old National Bancorp (ONB) Valuation After New Shelf Registration Filings

Why Old National Bancorp Filed New Shelf Registrations Old National Bancorp (ONB) recently filed multiple shelf registrations covering common stock, debt, preferred stock, depositary shares, warrants, purchase contracts, and units, including a separate ESOP related common stock offering totaling US$216.9 million. These filings do not commit the company to issue securities immediately. Instead, they give management a framework to raise capital or restructure funding relatively quickly if and...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

Assessing Construction Partners (ROAD) Valuation After Recent Share Pullback And Mixed Growth Signals

Recent share performance snapshot Construction Partners (ROAD) has drawn attention after the stock rose about 2.3% in the last trading day, even as it declined around 6% over the past week and 14% over the past month. See our latest analysis for Construction Partners. The recent setback, with a 30 day share price return down 14.2%, contrasts with a 1 year total shareholder return of 4.4% and a very large 3 year total shareholder return, hinting that momentum has cooled after a strong multi...
NasdaqGS:ADUS
NasdaqGS:ADUSHealthcare

A Look At Addus HomeCare (ADUS) Valuation After Recent Share Price Weakness

Recent share performance and valuation context Addus HomeCare (ADUS) has been under pressure recently, with the stock down about 9% over the past month and 13% over the past 3 months, leaving it roughly 16% lower year to date. Despite that pullback, the company reports annual revenue of US$1.45b and net income of US$99.75m. Its current share price of US$89.70 implies a market value of about US$1.62b. See our latest analysis for Addus HomeCare. The recent 1-day share price gain of 1.37% only...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Is There Still Opportunity In Amgen (AMGN) After Its 24% One-Year Share Price Gain

If you are wondering whether Amgen's share price still offers value, or if most of the opportunity is already priced in, this article walks through what the current valuation signals may be indicating. Amgen's stock recently closed at US$345.60, with returns of 2.7% over the last week, 4.9% over the last month, 5.5% year to date and 24.0% over the past year, which has many investors reassessing both its potential and its risks. Recent headlines around Amgen have focused on its position in...
NYSE:DFH
NYSE:DFHConsumer Durables

Is Dream Finders Homes (DFH) Undervalued After Recent Share Price Weakness And An 8.1x P/E Ratio

Recent trading context for Dream Finders Homes Dream Finders Homes (DFH) has drawn investor attention after a mixed return pattern, with the stock down over the past year while showing a small gain over the past month. See our latest analysis for Dream Finders Homes. The recent 7 day share price return, which is down 7.6% at a last close of US$14.35, sits against a weaker backdrop. The year to date share price return is down 16.3% and the 1 year total shareholder return is down 36.0%. This...
NYSE:MC
NYSE:MCCapital Markets

Assessing Moelis (MC) Valuation As Shares Show Strong Recent Momentum

Moelis stock moves and recent performance snapshot Moelis (MC) has drawn investor attention after recent trading, with the stock last closing at US$69.24. The company’s advisory-focused model and global footprint give investors several data points to assess current pricing. See our latest analysis for Moelis. Recent trading fits into a broader upswing, with a 9.1% 1 month share price return and 23.3% 3 month share price return sitting alongside a 25.7% 1 year total shareholder return and...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Is It Too Late To Consider Elanco Animal Health (ELAN) After Its 84% One-Year Surge?

If you are wondering whether Elanco Animal Health at around US$24.71 is priced for further upside or already reflecting high expectations, the valuation picture is where the real story starts. The stock has seen strong returns, with gains of 3.0% over 7 days, 7.5% over 30 days, 9.7% year to date and 84.0% over the past year, while the 3 year return is 164.3% and the 5 year return has declined 26.4%. Recent coverage has focused on how Elanco Animal Health is repositioning within animal health...
NasdaqGS:BYND
NasdaqGS:BYNDFood

How Beyond Meat’s Move Into Functional Beverages With Beyond Immerse (BYND) Has Changed Its Investment Story

Beyond Meat recently launched Beyond Immerse, a functional sparkling beverage line with plant protein, fiber, antioxidants, and electrolytes, into New York metro retail and foodservice locations via leading distributor Big Geyser. The move marks a meaningful expansion beyond plant-based meat into the fast-growing functional beverage space, potentially broadening Beyond Meat’s consumer reach and product mix. We’ll now examine how this push into functional beverages with Beyond Immerse could...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Assessing Qualcomm (QCOM) Valuation After A Strong Year And Recent Share Price Pullback

QUALCOMM stock at a glance QUALCOMM (QCOM) has drawn fresh attention after recent trading left the stock around $242.57, with returns over the past month and past 3 months sharply different from its 1-year and multi year performance. See our latest analysis for QUALCOMM. While the share price slipped 2.98% on the day to $242.57, QUALCOMM is still carrying strong recent momentum, with a 30-day share price return of 30.03% and a 90-day gain of 78.77% contributing to a 1-year total shareholder...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Anthropic IPO And AI Chips Put Amazon Valuation In New Focus

Anthropic has confidentially filed for an IPO that is reported to target a valuation around $1t, deepening its ties with Amazon.com (NasdaqGS:AMZN). Amazon, Anthropic’s lead corporate partner, reported a $16.8b pre tax gain in Q1 linked to its investment in the AI startup. Growth in demand for Amazon’s Trainium chips from Anthropic and other clients is reinforcing the role of Amazon Web Services in AI infrastructure. For investors watching Amazon.com at a share price of $253.79, this...
NYSE:WFC
NYSE:WFCBanks

Does Wells Fargo’s (WFC) New Bond Issuance Mark a Turning Point in Its Post‑Regulatory Strategy?

In late May 2026, Wells Fargo & Company launched and completed several senior unsecured, callable fixed‑income offerings across maturities from 2029 to 2046, including both fixed‑rate and step‑up notes priced at 100% with small underwriting discounts. This wave of issuance comes as Wells Fargo emerges from a decade-long Federal Reserve enforcement action, combining fresh funding activity with management’s confident outlook for growth in investment banking, trading, and wealth management...
NYSE:WM
NYSE:WMCommercial Services

How Investors May Respond To Waste Management (WM) Earnings Beat And Rising Institutional Interest

Waste Management, Inc. recently reported quarterly earnings that exceeded analyst expectations, supported by strong pricing and favorable price-to-cost spreads in its core Collection and Disposal segment. Institutional interest has increased, with the Mairs & Power Balanced Fund adding Waste Management in early 2026, citing its scale, route density, and vertically integrated landfill and recycling network as key competitive strengths. Now we’ll examine how these stronger-than-expected...
NYSE:NVGS
NYSE:NVGSOil and Gas

A Look At Navigator Holdings (NVGS) Valuation After 2026 Shipping Outlook And Ammonia Investment Updates

Insider moves and management commentary put Navigator Holdings (NVGS) in focus Navigator Holdings (NVGS) drew investor attention after CEO Mads Peter Zacho pointed to improved 2026 shipping conditions, while Chief Commercial Officer Oeyvind Lindeman recently sold 6,259 shares and now holds none. See our latest analysis for Navigator Holdings. Navigator Holdings’ share price has eased slightly in the past month, with a 1 month share price return of 3.76% down. However, the 90 day share price...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

A Look At Regencell Bioscience Holdings (RGC) Valuation After DOJ Subpoena And Shareholder Class Actions

Regencell Bioscience Holdings (RGC) has come under closer scrutiny after disclosing a U.S. Department of Justice subpoena into trading of its shares, with multiple shareholder class actions now challenging its past risk disclosures. See our latest analysis for Regencell Bioscience Holdings. The DOJ subpoena and wave of class actions have arrived after a sharp pullback in recent weeks, with the 30 day share price return down 18.74%, even though the total shareholder return over the past year...
NasdaqGS:OTTR
NasdaqGS:OTTRElectric Utilities

How Investors May Respond To Otter Tail (OTTR) Settling Key PVC Pipe Antitrust Claims

On May 28, 2026, Otter Tail Corporation said its Northern Pipe Products and Vinyltech subsidiaries agreed to pay US$39.5 million and US$34.0 million, respectively, to settle two of three plaintiff classes in an industry-wide PVC pipe antitrust case, while continuing to contest remaining end‑user claims. The company plans to use existing cash for these settlements, which it does not expect to materially affect its financial position or liquidity, while emphasizing that the agreements involve...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Opendoor Technologies (OPEN) Valuation Check As Russell 3000 Addition And AI Turnaround Plan Draw Fresh Interest

Opendoor Technologies (OPEN) is back in focus after news it will join the Russell 3000 Index, just as investors digest mixed Q1 results and an AI-focused turnaround plan that continues to attract attention. See our latest analysis for Opendoor Technologies. Despite a recent earnings driven sell off and a Q1 loss that kept risk front of mind, the stock has a very large 1 year total shareholder return and a 3 year total shareholder return of nearly 2x. At the same time, the year to date share...
NYSE:AMCR
NYSE:AMCRPackaging

Amcor Expands Healthcare Packaging Reach With India Build And Puerto Rico Upgrade

Amcor (NYSE:AMCR) is expanding its Sira, Karnataka facility in India to support rising healthcare packaging demand in South Asia. The company has also secured new cleanroom certification at its Carolina, Puerto Rico plant for sterile healthcare packaging. These moves add capacity and certified sterile capabilities across two key regions for medical and pharmaceutical customers. Amcor, which last closed at $37.64 and has seen the share price decline 10.5% year to date and 11.6% over the past...
NasdaqCM:RCAT
NasdaqCM:RCATAerospace & Defense

A Look At Red Cat Holdings (RCAT) Valuation As Drone And Maritime Expansion Plans Take Shape

Stock performance snapshot and business overview Red Cat Holdings (RCAT) has drawn attention after recent trading, with the stock closing at $14.74 and showing mixed short and longer term returns across the past week, month, past 3 months, and year. The company focuses on drone and robotic solutions for defense, national security, and commercial customers. All reported revenue of $54.57 million comes from recreational products in the United States, and the company has a market value of about...
NYSE:CRM
NYSE:CRMSoftware

Salesforce (CRM) Valuation Check After FIFA Partnership And Expanding Enterprise AI Push

Salesforce (CRM) is back in the spotlight after announcing a multi-tournament partnership as an Official Tournament Supporter for the FIFA World Cup 2026 and FIFA Women's World Cup 2027, showcasing its Agentforce 360 AI platform. See our latest analysis for Salesforce. The FIFA partnership arrives as Salesforce’s recent AI news, Anthropic stake, Contentful acquisition, guidance update, and dividend affirmation have all kept it in headlines, yet the share price is still down 25.6% year to...
NYSE:CNMD
NYSE:CNMDMedical Equipment

A Look At CONMED (CNMD) Valuation After GI Exit, Guidance Raise And Debt Refinancing

CONMED (CNMD) is reshaping its focus after selling its gastrointestinal product portfolio and raising full-year organic growth guidance, while also taking on a new bank term loan that increases interest costs but extends financing flexibility. See our latest analysis for CONMED. The refinancing news and portfolio reshaping helped lift the share price, with a 1-day share price return of 6.26%. However, this follows weaker momentum, including a 30-day share price return down 4.12% and a 1-year...
NasdaqGS:WWD
NasdaqGS:WWDAerospace & Defense

A Look At Woodward (WWD) Valuation After New Credit Agreements And Term Loan Refresh

Woodward (WWD) has refreshed its borrowing structure with a Third Amended and Restated Revolving Credit Agreement and a new term loan, refinancing existing debt and extending access to credit facilities to 2031. See our latest analysis for Woodward. The refinancing news comes after a strong run for investors, with the stock’s 1 year total shareholder return of 55.05% and 3 year total shareholder return of about 3.2x. However, the 90 day share price return is down 3.62%, hinting that momentum...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

If Tariffs Rise, These U.S. Manufacturing Stocks Could Benefit

With the U.S. trade agenda back in the spotlight, proposed new tariffs of 10% to 37.5% on imports from dozens of key partners are putting fresh attention on companies that actually make things inside the country. For investors, this kind of policy shift can reshape cost structures, supply chains and pricing power, creating potential winners and laggards. This article looks at 3 U.S. domestic manufacturing stocks that are exposed to these tariff headlines and that may be affected if production...
NYSE:BAH
NYSE:BAHProfessional Services

Is Booz Allen Hamilton (BAH) Still Attractive After Recent Share Price Weakness?

Wondering if Booz Allen Hamilton Holding is priced attractively or if the value story has already played out? This breakdown focuses squarely on what you are paying versus what you might be getting. The stock last closed at US$80.01, with the share price down 1.3% over the past week, up 4.9% over the past month, and down 5.7% year to date and 19.7% over the last year. Recent coverage of Booz Allen Hamilton has focused on its position as a major government and commercial consulting...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Is It Time To Reassess Johnson & Johnson (JNJ) After A 52% One-Year Surge?

If you are wondering whether Johnson & Johnson stock still offers value after a strong run, the key is to look closely at what the current price implies versus what you are getting as a shareholder. The stock last closed at US$228.17, with returns of 10.0% year to date and 52.2% over the past year. The share price has slipped about 1.1% over the past week and gained 1.2% over the last 30 days, hinting that views on risk and reward are still shifting. Recent headlines around Johnson & Johnson...